Immatics (IMTX) awards director Alise Reicin 48,000 stock options

Rhea-AI Filing Summary

Immatics N.V. director Alise Reicin reported a compensation-related award of stock options. She received 48,000 Stock Options (Right to Buy) to acquire Immatics ordinary shares.

The options carry an exercise price of $9.09 per share, expire on June 15, 2036, and vest 100% on June 16, 2026. Following this grant, Reicin holds 48,000 derivative securities of this type directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider REICIN ALISE

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	48,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 48,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock options granted: 48,000 options Exercise price: $9.09 per share Expiration date: June 15, 2036 +2 more

5 metrics

Stock options granted 48,000 options Grant to director Alise Reicin

Exercise price $9.09 per share Stock Option (Right to Buy)

Expiration date June 15, 2036 Option term end

Vesting date June 16, 2026 Options vest 100% on this date

Derivative holdings after grant 48,000 options Total shares following transaction

Key Terms

Stock Option (Right to Buy), Ordinary Shares, Grant, award, or other acquisition, exercise price

4 terms

Stock Option (Right to Buy) financial

"security_title is listed as "Stock Option (Right to Buy)""

Ordinary Shares financial

"underlying security title is stated as "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Grant, award, or other acquisition financial

"transaction code description reads "Grant, award, or other acquisition""

exercise price financial

"conversion or exercise price is shown as 9.0900 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

REICIN ALISE

(Last) (First) (Middle)

PAUL-EHRLICH-STR. 15

(Street)

TUBINGEN 72076

(City) (State) (Zip)

GERMANY

(Country)

2. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$9.09	06/16/2026		A		48,000		(1)	06/15/2036	Ordinary Shares	48,000	$0	48,000	D

Explanation of Responses:

1. These Options vest 100% on the first anniversary of the grant date, June 16, 2026.

	/s/ Edward Sturchio, attorney-in-fact for Alise Reicin	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Immatics (IMTX) report for Alise Reicin?

Immatics reported that director Alise Reicin received a grant of 48,000 stock options as compensation. These options give her the right to buy Immatics ordinary shares at a fixed exercise price, rather than representing an open-market share purchase or sale.

What are the key terms of Alise Reicin’s Immatics (IMTX) stock options?

Alise Reicin’s grant covers 48,000 stock options with an exercise price of $9.09 per share. The options expire on June 15, 2036, providing a long exercise window, and are tied to Immatics’ ordinary shares as the underlying security.

When do Alise Reicin’s Immatics (IMTX) stock options vest?

The Form 4 notes that these options vest 100% on June 16, 2026. This means Reicin must wait until that date before she can exercise any of the 48,000 options to buy Immatics ordinary shares at the fixed $9.09 exercise price.

How many Immatics (IMTX) derivative securities does Alise Reicin hold after this grant?

After the reported transaction, Alise Reicin beneficially owns 48,000 derivative securities of this option type directly. This total equals the full size of the new grant, indicating these options constitute her reported holdings of this specific derivative class.

Does the Immatics (IMTX) Form 4 show Alise Reicin buying or selling shares on the market?

The Form 4 describes a grant of stock options, classified as a “Grant, award, or other acquisition.” It does not report any open-market share purchases or sales; instead, it records compensation-related options giving future rights to acquire ordinary shares.